Insider · CIK 0001222082
Cynthia M Butitta
director
Files at URGN (UroGen Pharma Ltd.), OLMA (Olema Pharmaceuticals, Inc.), IPSC (Century Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise ordinary shares | +2,000 | - | - | 2,000 | Dec 1, 2025 |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | MOption exercise Restricted Stock Unitderivative | -2,000 | $0.00 | $0 | 6,000 | Dec 1, 2025 |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Stock Option (right ot buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Aug 27, 2025 |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | AGrant or award Restricted Stock Unitderivative | +8,000 | $0.00 | $0 | 8,000 | Aug 27, 2025 |
| Jun 12, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 16, 2025 |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +24,150 | $0.00 | $0 | 24,150 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.